OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
April 10, 2008
Also, Jubilant Organosys to acquire DRAXIS Health, PPD's Paul Covington to retire, more...
April 03, 2008
Also, VaxGen and Raven terminate merger agreement, Darren Head appointed CEO of Cytovance, more...
April 02, 2008
Although there have been recent setbacks for China with regard to exported products, the country has made substantial strides in its pharmaceutical industry over the past few years. Intense competition and a series of new regulations seem to be moving the country into a period of recovery.
The recent heparin contamination event calls for a new approach to manage a lengthening pharmaceutical supply chain.
The FDA itself issues a cry for help. Is anybody listening?
CMOs have positive outlook for 2008 but are wary of competitive pressures.
Brief pharmaceutical news items for April 2008.
April 01, 2008
Most CROs are entering China with expectations that a significant local market opportunity will develop as major pharmaceutical companies establish research development operations there...
Biopharmaceuticals are the most rapidly growing segment of the pharmaceuticals market. Developing and marketing biopharmaceuticals are huge roles in almost every major pharmaceutical company's strategy. However, they are extremely complex molecules and are highly sensitive to the manufacturing processes used to produce them. These processes require exquisite control of living production systems, making, without a doubt, biopharmaceuticals one of the most challenging products of any type to manufacture.